Drugs / Marrow-derived mesenchymal stromal cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04018729 | Nov 2019 → Aug 2020 overdue | chronic obstructive pulmonary disease | Hospital de Clinicas de Porto Alegre | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Marrow-derived mesenchymal stromal cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04018729 ↗ |
| Route | Other | “endoscopic administration of bone marrow stem cells” NCT04018729 ↗ |